1-(4-fluorobenzoyl)-3-(((6-methoxy-2-naphthyl)oxy)methyl)azetidine-3-carboxylic acid,
PF-04418948,
PF-04418948,
1078166-57-0,
PF 04418948,
UNII-I7Z38E70VF,
I7Z38E70VF,
PF04418948,
LWJGMYMNSNVCEM-UHFFFAOYSA-N,
GTPL5817,
SCHEMBL3632622,
CHEMBL3286797,
DTXSID80148292,
BCP24203,
EX-A1253,
s7211,
ZINC95644391,
AKOS024458362,
CS-5011,
DB12024,
NCGC00371019-02,
AK316254,
HY-18966,
B5726,
1-(4-fluorobenzoyl)-3-((6-methoxynaphthalen-2-yloxy)methyl)azetidine-3-carboxylic acid,
1-(4-fluorobenzoyl)-3-[(6-methoxynaphthalen-2-yl)oxymethyl]azetidine-3-carboxylic acid,
1-(4-Fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]-3-azetidinecarboxylic acid,
1-(4-Fluorobenzoyl)-3-{[(6-methoxy-2-naphthyl)oxy]methyl}azetidine-3-carboxylic acid,
3-Azetidinecarboxylic acid, 1-(4-fluorobenzoyl)-3-[[(6-methoxy-2-naphthalenyl)oxy]methyl]-,
D0S5EF,
PF-4418948,
A12894,
Prostaglandin E2 EP2 subtype antagonist (endometriosis), Pfizer,